Beta2 Glycoprotein and IgM At

The Beta2 Glycoprotein and IgM At test, offered at IntroLab in Belgrade, is a key diagnostic tool for identifying antiphospholipid syndrome (APS) and other autoimmune disorders. This test detects specific antibodies in the blood, offering important insights into your health.

What are Beta-2 Glycoprotein antibodies?

Beta-2 glycoprotein is a crucial protein in the blood that plays a role in the coagulation process. In autoimmune conditions, the body may produce antibodies against this protein. Testing for these antibodies can aid in diagnosing these conditions.

When and for whom is the Beta2 Glycoprotein and IgM At test recommended?

The test is recommended for individuals with symptoms or a medical history of thrombosis, as well as for women who have had recurrent miscarriages. It is also valuable for patients with lupus or other autoimmune disorders. This test is particularly important when there is a suspicion of antiphospholipid syndrome (APS) or when other tests suggest an increased risk of blood clot formation, providing crucial diagnostic insights.

Interpreting the results

The interpretation of results is highly dependent on the clinical context. A positive antibody result may suggest the presence of antiphospholipid syndrome (APS), but it does not confirm the diagnosis on its own. Additional tests may be required to reach a definitive conclusion.

Subtypes of the test

Beyond the Beta2 Glycoprotein and IgM At test, other antibody classes can be analyzed to provide a more complete picture of the immune response:

• Beta2 Glycoprotein and IgG At Test: This test identifies the presence of IgG antibodies against Beta-2 glycoprotein.
• Beta2 Glycoprotein and IgA At Test: This test detects IgA antibodies against Beta-2 glycoprotein.

Each class of antibodies can reveal different aspects of the immune response, making a combination of these tests useful for a thorough diagnostic evaluation.